BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 19, 2003
View Archived Issues
Genta Receives Ganite Approval In Cancer-Related Hypercalcemia
Genta Inc. received its first drug approval Thursday when the FDA cleared Ganite for the treatment of cancer-related hypercalcemia that is resistant to hydration. (BioWorld Today)
Read More
Memory Signs Roche To $150M Expansion Of CNS Collaboration
Read More
454 Life Sciences Secures $20M To Begin Commercial Operations
Read More
Conforma Placement Raises $30M For Cancer Therapies
Read More
Neurochem Increases IPO Share Amount, Expects To Raise $54M
Read More
Other News To Note
Read More